Global Effect of PEG-IFN-α and Ribavirin on Gene Expression in PBMC in Vitro

Journal of Interferon and Cytokine Research

Volumn 24, Issue 2, 2004, Pages 107-118

  Taylor, Milton W ^a   Grosse, William M ^a   Schaley, Joel E ^a   Sanda, Corneliu ^a   Wu, Xiaoning ^b   Chien, Shih Chang ^b   Smith, Fred ^b   Wu, Thomas G ^b   Stephens, Matthew ^c   Ferris, Mary W ^a   McClintick, Jeanette N ^c   Jerome, Ronald E ^c   Edenberg, Howard J ^c  

^a INDIANA UNIVERSITY   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ACTIVATING TRANSCRIPTION FACTOR 4; CHEMOKINE; CXCL11 CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HOMEODOMAIN PROTEIN; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; OLIGONUCLEOTIDE; PEGINTERFERON ALPHA2B; PROPERDIN; RIBAVIRIN; RNA EDITING ENZYME; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS;

CELLS, CULTURED; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LYMPHOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYETHYLENE GLYCOLS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER;

EID: 10744220110     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999004322813354     Document Type: Article

References (43)

1. COTLER, S.J., REDDY, K.R., McCONE, J., WOLFE, D.L., LIU, A., CRAFT, T.R., FERRIS, M., CONRAD, A., ALBRECHT, J., MORRISEY, M., GANGER, D., ROSENBLATE, H., BLATT, L.M., JENSEN, D.M., and TAYLOR, M.W. (2001). An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon. J. Interferon Cytokine Res. 21, 1011-1019.
2. COTLER, S.J., CRAFT, T., FERRIS, M., MORRISEY, M., McCONE, J., REDDY, R.K., CONRAD, A., JENSEN, D.M., ALBRECHT, J., and TAYLOR, M.W. (2002). Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1. J. Interferon Cytokine Res. 22, 549-554.
3. McCLINTICK, J.N., JEROME, R.E., NICHOLSON, C.R., CRABB, D.W., and EDENBERG, H.J. (2003). Reproducibility of oligonucleotide arrays using small samples. BMC Genomics 4, 4. www.biomedcentral.com/1471-2164/4/4.
4. EISEN, M.B., SPELLMAN, P.T., BROWN, P.O., and BOTSTEIN, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
5. HIGUCHI, R., and WATSON, R. (1999). Kinetic PCR analysis using a CCD camera and without using oligonucleotide probes. In: PCR Applications. M.A. Innis, D.H. Gelfand, and J.J. Sninsky (eds.) San Diego: Academic Press, pp. 263-284.
6. DE VEER, M.J., HOLKO, M., FREVEL, M., WALKER, E., DER, S., PARANJAPE, J.M., SILVERMAN, R.H., and WILLIAMS, B.R. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J. Leukocyte Biol. 69, 912-920.
7. DER, S.D., ZHOU, A., WILLIAMS, B.R., and SILVERMAN, R.H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 15623-15628.
8. JI, X., CHEUNG, R., COOPER, S., LI, Q., GREENBERG, H.B., and HE, X.S. (2003). Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 37, 610-621.
9. RAJEEVAN, M.S., VERNON, S.D., TAYSAVANG, N., and UNGER, E.R. (2001). Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR, J. Molec. Diagn. 3, 26-31.
10. JARMUZ, A., CHESTER, A., BAYLISS, J., GISBOURNE, J., DUNHAM, I., SCOTT, J., and NAVARATNAM, N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
11. SAMUEL, C.E. (2001). Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809.
12. SCHWAEBLE, W.J., and REID, K.B.M. (1999). Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20, 17-21.
13. ZHANG, C., GAO, C., KAWAUCHI, J., HASHIMOTO, Y., TSUCHIDA, N., KITAJIMA, S. (2002). Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter p53 Biochem. Biophys. Res. Commun. 297, 1302-1310.
14. TAJIMA, T., HATTORRI, T., NAKAJIMA, T., OKUHARA, K., SATO, K., ABE, S., NAKAE, J., and FUJIEDA, K. (2003). Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J. Clin. Endocrinol. Metab. 88, 45-50.
15. D'ARENA, G., DI RENZO, N., BRUGIATELLI, M., VIGLIOTTI, M.L., and KEATING, M.J. (2003). Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia. Leuk. Lymphoma 44, 223-228.
16. KHODADOUST, M.M., KHAN, K.D., and BOTHWELL, A.L. (1999). Complex regulation of Ly-6E gene transcription in T cells by IFNs. J. Immunol. 163, 811-819.
17. CHIN, K.C., and CRESSWELL, P. (2001). Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 98, 15125-15130.
18. SHUAI, K. (2000). Modulation of Stat signaling by Stat-interacting proteins. Oncogene 19, 2638-2644.
19. O'SHEA, J.J., GADINE, M., and SCHREIBER, R.D. (2002). Cytokine signaling in 2002. New surprises in the Jak/Stat pathway. Cell 109, 121-131.
20. KIM, S., NA, J.G., HAMPSEY, M., and REINBERG, D. (1997). The DR1/DRAM heterodimer is a global repressor of transcription in vivo. Proc. Natl. Acad. Sci. USA 94, 820-825.
21. TANIGUCHI, T. (1997). Transcription factors IRF-1 and IRF-2 linking the immune response and tumor suppressors. J. Cell. Physiol. 173, 128-130.
22. BAETU, T.M., and HISCOTT, J. (2002). On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 13, 199-207.
23. HYMOWITZ, S.G., CHRISTINGER, H.W., FUH, G., ULTSCH, M., O'CONNELL, M., KELLEY, R.F., ASHKENAZI, A., and DE VOS, A.M. (1999). Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4, 563-571.
24. KOBAYASHI, K., INOHARA, N., HERNANDEZ, L.D., GALAN, J.E., NUNEZ, G., JANEWAY, C.A., MEDZHITOV, R., and FLAVELL, R.A. (2002). RICK/Rip2/CARDIAK mediates signaling for receptors of the innate and adaptive immune systems. Nature 416, 194-199.
25. SCHLAAK, J.F., HILKEN, C.M., COSTA-PEREIRA, A.P., STROBL, B., ABERGER, F., FRISCHAUF, A.M., and KERR, I.M. (2002). Cell type and donor specific transcriptional responses to Interferon alpha: use of customized gene arrays J. Biol. Chem. 277, 49428-49437.
26. SIDWELL, R.W., HUFFMAN, J.H., KHARE, G.P., ALLEN, L.B., WITKOWSKI, J.T., and ROBINS, R.K. (1972). Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177, 705-706.
27. LEE, J.H., VON WAGNER, M., ROTH, W.K., TEUBER, G., SARRAZIN, C., and ZEUZEM, S. (1998). Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus. J. Hepatol. 29, 29-35.
28. MARTIN, J., NAVAS, S., QUIROGA, J.A., PARDO, M., and CARRENO, V. (1998). Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 10, 635-644.
29. TAM, R.C., PAI, B., BARD, J., LIM, C., AVERETT, D.R., PHAN, U.T., and MILOVANOVIC, T. (1999). Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. J. Hepatol. 30, 376-382.
30. CONTRERAS, A.M., HIASA, Y., HE, W., TERELLA, A., SCHMIDT, E.V., and CHUNG, R.T. (2002). Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system J. Virol. 76, 8505-8517.
31. RUTKOWSKI, D.T., and KAUFMAN, R.J. (2003). All roads lead to ATF4. Dev. Cell 4, 442-444.
32. NAKANISHI, K., YOSHIMOTO, T., TSUTSUI, H., and OKAMURA, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423-474.
33. DAO, T., OHASHI, K., KAYANO, T., KURIMOTO, M., and OKAMURA, H. (1996). Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cell. Immunology 173, 230-235.
34. TSUTSUI, H., NAKANISHI, K., MATSUI, K., HIGASHINO, K., OKAMURA, H., MIYAZAWA, Y., and KANEDA, K. (1996). IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157, 3967-3973.
35. TRENTIN, L., ZAMBELLO, R., FACCO, M., SANCETTA, R., AGOSTINI, C., and SEMENZATO, G. (1997). Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymphoma 27, 35-42.
36. WALDMANN, T., TAGAYA, Y., and BAMFORD, R. (1998). Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16, 205-226.
37. GRABSTEIN, K.H., EISENMAN, J., SHANEBECK, K., RAUCH, C., SRINIVASAN, S., FUNG, V., BEERS, C., RICHARDSON, J., SCHOENBORN, M.A., AHDIEH, M., et al. (1994). Cloning of a T-cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264, 965-968.
38. BURTON, J.D., BAMFORD, R.N., PETERS, C., GRANT, A.J., KURYS, G., GOLDMAN, C.K., BRENNAN, J., ROESSLER, E., and WALDMANN, T.A. (1994). A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91, 4935-4939.
39. CACCIARELLI, T.V., MARTINEZ, O.M., GISH, R.G., VILLANUEVA, J.C., and KRAMS, SM. (1996). Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post-treatment with interferon alfa. Hepatology 24, 6-9.
40. KISHIHARA, Y., HAYASHI, J., YOSHIMURA, E., YAMAJI, K., NAKASHIMA, K., and KASHIWAGI, S. (1996). IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 41, 315-321.
41. STYLIANOU, E., AUKRUST, P., BENUTZEN, K., MULLER, F., and FROLAND, S.S. (2000). Interferons and interferon (IFN)-inducible protein 10 during highly active antiretroviral therapy (HAART) - possible immunosuppressive role of IFN-alpha in HIV infection. Clin. Exp. Immunol. 119, 479-485.
42. GUO, B., GODZIK, A., and REED, J.C. (2001). Bcl-G, a novel proapoptotic member of the Bcl-2 family. J. Biol. Chem. 276, 2780-2785.
43. LEE, M.P., and FEINBERG, A.P. (1998). Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res. 58, 1052-1056.